BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential

뉴스 본문을 불러오고 있어요.

BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential | 웨이프 WAPE

BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential

기사 요약

관련 종목

댓글 —